Jiangsu Kingsley Pharmaceutical

Jiangsu Kingsley Pharmaceutical is a comprehensive pharmaceutical enterprise located in Wuxi, China, dedicated to the research, production, and sale of chemical APIs and finished drug products. The company has established a significant presence in the cardiovascular and gastroenterology markets, producing key generic medications such as statins and proton pump inhibitors. Kingsley Pharmaceutical operates state-of-the-art manufacturing facilities that adhere to international GMP standards, enabling them to serve both the Chinese domestic market and international clients. Their business model encompasses the entire value chain from advanced intermediate synthesis to final formulation. By focusing on high-barrier generic drugs and innovative drug delivery systems, the company maintains a competitive edge in the specialty pharma sector. Kingsley is recognized for its commitment to quality control and its robust R&D capabilities in small molecule chemistry.